Literature DB >> 15202617

Dementia and antihypertensive treatment.

Willem H Birkenhäger1, Françoise Forette, Jan A Staessen.   

Abstract

PURPOSE OF REVIEW: We present an updated overview on the long-term effects of hypertension on the occurrence of cognitive dysfunction and overt degenerative or vascular dementia later in life. The preventative effects of antihypertensive treatment in this regard are examined, with a focus on placebo-controlled, double-blind, randomized prospective trials. RECENT
FINDINGS: The stereotypical straightforward linear relationship between mid-life hypertension and dementia later in life can no longer be considered strictly invariable. Successfully treated hypertensive patients who are still at risk for clinical dementia late in life may ultimately fare better in the presence of a slightly elevated rather than low systolic blood pressure. The mechanisms underlying this 'J-curve' phenomenon are currently being explored. Recently completed prospective randomized antihypertensive trials (Syst-Eur 2, PROGRESS and SCOPE) have yielded variable results, and merit cautious interpretation.
SUMMARY: The incidence and prevalence of dementia are increasing exponentially worldwide, particularly in those older than 70 years. Because hypertension predisposes to dementia, therapeutic blood pressure titration should be maintained over the years, and intensified beyond 70 years in order to avoid over-treatment in the latter period.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15202617     DOI: 10.1097/00041552-200403000-00011

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  7 in total

Review 1.  Vasculopathy of Aging and the Revised Cardiovascular Continuum.

Authors:  Su-A Kim; Jeong Bae Park; Michael F O'Rourke
Journal:  Pulse (Basel)       Date:  2015-08-20

2.  Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor.

Authors:  Matthew L Hemming; Dennis J Selkoe
Journal:  J Biol Chem       Date:  2005-09-09       Impact factor: 5.157

3.  Cardiovascular drug use among people with cognitive impairment living in nursing homes in northern Sweden.

Authors:  Sofia Svahn; Hugo Lövheim; Ulf Isaksson; Per-Olof Sandman; Maria Gustafsson
Journal:  Eur J Clin Pharmacol       Date:  2020-01-08       Impact factor: 2.953

Review 4.  The evidence for treating hypertension in older people with dementia: a systematic review.

Authors:  L C Beishon; J K Harrison; R H Harwood; T G Robinson; J R F Gladman; S P Conroy
Journal:  J Hum Hypertens       Date:  2013-11-07       Impact factor: 3.012

5.  Angiotensin-converting enzyme converts amyloid beta-protein 1-42 (Abeta(1-42)) to Abeta(1-40), and its inhibition enhances brain Abeta deposition.

Authors:  Kun Zou; Haruyasu Yamaguchi; Hiroyasu Akatsu; Takaaki Sakamoto; Mihee Ko; Kazushige Mizoguchi; Jian-Sheng Gong; Wenxin Yu; Takayuki Yamamoto; Kenji Kosaka; Katsuhiko Yanagisawa; Makoto Michikawa
Journal:  J Neurosci       Date:  2007-08-08       Impact factor: 6.167

6.  The dynamics of blood pressure and cognitive functioning: results from 6-year follow-up of an elderly cohort.

Authors:  Ester Paran; Ofra Anson
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-08-24       Impact factor: 3.738

Review 7.  New horizons: the management of hypertension in people with dementia.

Authors:  Jennifer Kirsty Harrison; Veronika Van Der Wardt; Simon Paul Conroy; David J Stott; Tom Dening; Adam Lee Gordon; Pip Logan; Tomas James Welsh; Jaspal Taggar; Rowan Harwood; John R F Gladman
Journal:  Age Ageing       Date:  2016-11       Impact factor: 10.668

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.